Skip to main content

Table 2 Results of further investigation on included patients with detected focal incidental breast uptake*

From: Prevalence of focal incidental breast uptake on FDG-PET/CT and risk of malignancy: a systematic review and meta-analysis

Items

Lost to follow-up

Included FIBU**

Detected lesions***

Primary BC****

Studies

Benign

Malignant

Chae et al. (2012)

60 (45.8)

71

39 (54.9)

32 (45.1)

27 (84.38)

Kim et al. (2012)

0 (0)

27

12 (44.4)

15 (55.6)

13 (86.67)

Dunne et al. (2013)

11 (28.9)

39

18 (43.6)

17 (43.6)

15 (88.24)

Lim et al. (2013)

10 (76.7)

33

24 (72.7)

9 (27.3)

9 (100)

Minamimoto et al. (2015)

NR

317

NR

135 (42.6)

123 (91.1)

Benveniste et al. (2015)

83 (18.9)

355

195 (54.9)

160 (45.1)

25 (15.63)

Bertagna et al. (2015)

44 (55.6)

35

10 (28.6)

25 (71.4)

23 (92.00)

Shin et al. (2015)

123 (57.4)

91

64 (70.3)

27 (29.7)

25 (92.59)

  1. *Data was shown as frequency (percentage)
  2. **Final included FIBU patients after lost to follow-up
  3. ***Classification to malignant and benign lesion were done based on histopathology results
  4. ****Frequency and percentage of primary breast cancer patients out of detected malignant lesions
  5. NR not reported, FIBU focal incidental breast uptake, BC breast cancer